EURAZEO Becomes New Shareholder in Moria Alongside Naxicap Partners

Paris, September 5, 2024 — EURAZEO has joined Moria, a leader in ophthalmic microsurgery instruments, as a minority shareholder alongside Naxicap Partners. This partnership arrives five years after Naxicap Partners' initial investment in Moria.

Moria, founded in 1820, specializes in manufacturing equipment and instruments for ophthalmic surgery, servicing hospitals globally. Their products, including over 2,200 items, cover essential surgical procedures like corneal, cataract, refractive, and retinal surgeries. Moria operates from facilities in France and Italy, with commercial subsidiaries in the United States, Japan, China, and Italy.

Since the 2019 LBO led by Naxicap Partners, Moria’s revenue has grown from €30m to €55m, further solidifying its market position. The company also acquired the Italian firm Alchimia, focused on retinal and corneal surgery.

The current LBO aims to accelerate Moria’s external growth strategy and innovation efforts. EURAZEO's Nov Santé Actions Non Cotées Fund is investing €35m in this venture, with additional financing from Bridgepoint Credit.